Shanghai Pharmaceuticals Holding Co., Ltd (OTCMKTS:SHPMF) Short Interest Update

Shanghai Pharmaceuticals Holding Co., Ltd (OTCMKTS:SHPMF) saw a large decline in short interest in March. As of March 15th, there was short interest totalling 636,500 shares, a decline of 70.3% from the February 28th total of 2,146,200 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Shanghai Pharmaceuticals Stock Performance

Shanghai Pharmaceuticals stock remained flat at $1.56 during midday trading on Friday. Shanghai Pharmaceuticals has a fifty-two week low of $0.99 and a fifty-two week high of $1.95. The business has a fifty day simple moving average of $1.47 and a two-hundred day simple moving average of $1.47.

Shanghai Pharmaceuticals Company Profile

Shanghai Pharmaceuticals Holding Co, Ltd. engages research, development, manufacture, distribution, and retailing of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including digestive system, immune metabolism, motor neuron disease, endocrinology, cardiovascular, psychoneurotic, neoplasm, autoimmunity, systemic anti-infection, mental nerve, anti-tumor, oncology, respiratory system, nervous system, auto-immunity, hypertension, neuromyelitis, diabetes, anticholinesterase, polypeptide hormones uterine tonic, antihistamine, anti-inflammatory, anesthetic, immunomodulatory, antiviral, reflux esophagitis, analgesics, weight management, malignant peritoneal effusion, ulcerative colitis, myasthenia gravis, burn injury, anticoagulant, anti-epileptic, anticonvulsant, Alzheimer’s, and inflammatory bowel diseases.